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Abstract
Background: The role of coronary atherosclerosis (CA+) in ventricular remodeling after
aortic valve replacement (AVR) for isolated aortic stenosis (AS) is not well defined. We sought
to evaluate the impact of not revascularized moderate coronary atherosclerosis in long-term left
ventricular (LV) remodeling after AVR.
Methods: We assessed by coronariography the coronary artery disease in 66 patients referred
for AVR and evaluated morphological and functional LV data by echocardiography both pre-
operatively and postoperatively (3 ± 1.2 years).
Results: In patients without coronary atherosclerosis, hypertrophy regression was more in-
tense and the absolute reverse remodeling was higher in LV mass index (–55.8 ± 36 g/m2 vs
–28.4 ± 34 g/m2, p = 0.004), reduction of LV dimensions (LV end-diastolic diameter
[LVEDD]: –4.1 ± 7.4 mm vs –2.2 ± 8.3 mm, p = 0.04), and regression of wall thickness
(interventricular septum [IVS]: –3.3 ± 2.6 mm vs –1.6 ± 2.2 mm, p = 0.01; and posterior
wall thickness [PWT]: –2.1 ± 2.1 mm vs 0.6 ± 2.1 mm, p = 0.012).
Conclusions: After AVR for AS, not revascularized moderate coronary atherosclerosis deter-
mines a long-term lesser degree of LV hypertrophy regression and a worse absolute reverse
remodeling of LV mass index, LVEDD, IVS and PWT. (Cardiol J 2011; 18, 3: 277–281)
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Introduction
Aortic stenosis (AS) determines left myocar-
dial hypertrophy due to chronic systolic pressure
overload. Prosthetic aortic valve replacement
(AVR) for isolated AS determines a marked left
ventricular mass index (LVMI) decrease, with re-
duction of dimensions and wall thickening of the left
ventricle [1]. The role of coronary atherosclerosis
in this ventricular remodeling has not been proper-
ly established. We aimed to evaluate the impact of
moderate non-revascularized coronary atherosclero-
sis in long-term LV remodeling after AVR for AS.
Methods
The study population consisted of consecutive
survivors referred for AVR for isolated AS with no
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coronary artery bypass grafts (CABG) performed
during the surgical intervention (absence of angio-
graphic coronary stenosis or not severe coronary
stenosis). Each patient underwent standard coro-
narography before surgery. The absence of angio-
graphic coronary stenosis (CA–) was defined as
smooth and regular walls in three vessels. Mode-
rate coronary atherosclerosis (CA+) was defined
as the presence of ≥ one vessel with stenosis
≥ 40% and < 80% by quantitative coronary angiog-
raphy. Patients with a history of myocardial infarc-
tion (MI) were excluded. CABG during AVR was
decided jointly by a cardiologist and a surgeon, de-
pending on coronary stenosis severity. All surgical
interventions were performed by the same surgi-
cal team at another hospital.
At basal characterization, hypertension, dysli-
pidemia and diabetes mellitus were defined as spe-
cific chronic pharmacological medical treatment for
these pathologies. Smoking was defined as an ac-
tive smoker or one who had stopped during the pre-
vious ten years.
All patients underwent Doppler echocardio-
graphy preoperatively and were re-evaluated three
years after surgery (mean 36.5 ± 14 months). All
echocardiographic studies were performed by the
same experienced work team using the same equip-
ment (Philips Envisor). Echocardiographic end-dia-
stolic (LVEDD) and end-systolic (LVESD) mea-
surements of LV dimensions, interventricular sep-
tal thickness (IVS) and posterior wall thickness
(PWT) were obtained in millimeters, according to
the Guidelines of the American Society of Echocar-
diography [2]. LVMI was calculated according to
body surface area [m2] as described by Devereux
[3]. Left ventricular ejection fraction (LVEF) was
estimated by Teicholz method [2], and systolic dys-
function was defined as LVEF < 50%. Reverse re-
modeling was calculated by arithmetic subtraction
between the preoperative and postoperative mea-
surements.
The study was approved by the local bioethi-
cal committee and all patients gave their informed
consent.
Statistical analysis
Statistical analysis was performed using com-
puter data (SPSS 13.0 software). Values are ex-
pressed as mean ± standard deviation for continous
variables, and percentages for qualitative variables.
Paired and independent comparisons between pre-
operative and postoperative studies were perfor-
med using the two tailed Student-t test. Qualitative
comparisons were performed using the c2 test. The
level of significance was established at p < 0.05
Results
A total of 66 patients were enrolled (aged 67.6 ±
± 8.8 years, 44 male): 42 in group CA– and 24 in
group CA+. Both groups of patients presented simi-
lar basal characteristics (Table 1): age at surgery
(66.7 ± 9.6 years in CA– vs 69.1 ± 7.2 years in
CA+, p = 0.3); body surface area (1.7 ± 0.1 m2 vs
Table 1. Baseline characteristics of patients.
CA– CA+ P
Age 66.7 ± 9.6 69.1 ± 7.2 0.3
Body surface area [m2] 1.7 ± 0.1 1.8 ± 0.1 0.16
Hypertension 10 (23.8%) 5 (20.8%) 0.78
Dyslipidemia 8 (19%) 6 (25%) 0.56
Diabetes mellitus 4 (9.5%) 5 (20.8%) 0.19
Smoking 6 (14.3%) 6 (25%) 0.27
Number of vessels diseased:
1 0 (0%) 13 (54.2%)
2 0 (0%) 7 (29.2%)
3 0 (0%) 4 (16.7%)
LVMI [g/m2] 161.5 ± 49.4 148.6 ± 31 0.25
LVEF (%) 57 ± 11 59 ± 14 0.6
Systolic dysfunction 8 (19%) 4 (16.7%) 0.8
Peak gradient [mm Hg] 92 ± 25 93 ± 22 0.92
Medium gradient [mm Hg] 58 ± 18 58 ± 11 0.88
CA– — absence angiographic coronary stenosis; CA+ — moderate coronary atherosclerosis; LVMI — left ventricular mass index; LVEF — left ventricular
ejection fraction
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1.8 ± 0.1 m2, p = 0.16); prevalence of hypertension
(23.8% vs 20.8%, p = 0.78); LVMI (161.5 ± 49.4 g/m2
vs 148.6 ± 31 g/m2, p = 0.25); LVEF (57 ± 11% vs
59 ± 13%, p = 0.6); systolic dysfunction (19% vs
16.7%, p = 0.8) and transvalvular aortic gradients
(peak gradient: 92 ± 25 mm Hg vs 93 ± 22 mm Hg,
p = 0.92, medium gradient: 58 ± 18 mm Hg vs 58 ±
± 11 mm Hg, p = 0.88). CA+ was more frequent
in men than in women (47.7% vs 13.6%; p = 0.007;
RR 3.5; 95%CI 1.17–10.4). Besides moderate steno-
sis in other vessels, three patients presented
70–80% stenosis by QCA [4], but in distal segments
or small branches not suitable for CABG (one pa-
tient in a distal right posterolateral branch, and two
patients in distal marginal obtuse branches with dif-
fuse atheroesclerosis and vessel size reduction in
distal segments).
Mechanical prostheses were implanted in simi-
lar ratios in both groups (61.9% in CA– vs 56.5% in
CA+, p = 0.67). After AVR transvalvular aortic gra-
dients did not differ (peak gradient: 27 ± 12 mm Hg
vs 23 ± 8 mm Hg, p = 0.15; medium gradient:
15 ± 7 mm Hg vs 13 ± 3 mm Hg, p = 0.14).
Changes in LV morphology from preoperative
to postoperative measurements are displayed in
Table 2. In the CA– group, all the echocardiographic
parameters evaluated decreased between the pre-
operative and the postoperative study (except for
a LVEF increase), but in the CA+ group only IVS
and LVMI changed significantly. The differences in
absolute reverse remodeling in LVEDD, IVS, PWT
achieved statistical significance between both
groups. LVMI suffered a noticeable drop in both
groups, but there was a remarkable difference in its
absolute reverse remodeling (–55.8 ± 36 g/m2 vs
–28.4 ± 34 g/m2, p = 0.004, Fig. 1). LVEF increased
significantly in CA–, but there were no differences
between both groups.
Table 2. Changes in left ventricular morphology from preoperative to postoperative measurements in
both groups (regression of wall thickness and reduction of left ventricular dimensions) and differences
in remodeling between them.
CA– CA+
Pre Post P Pre Post P
LVEDD [mm] 52.3 ± 7.6 48 ± 5.9 < 0.001 52.4 ± 7.9 50.9 ± 5.2 0.42
   remodeling –4.1 ± 7.4 –2.2 ± 8.3 0.04
LVESD [mm] 34.1 ± 8.2 30 ± 5.3 0.001 33.8 ± 9.2 31.3 ± 4.3 0.19
   remodeling –3.7 ± 7.3 –3.2 ± 8.8 0.79
IVS [mm] 13.4 ± 2.9 10.2 ± 2.2 < 0.001 12.4 ± 2.1 10.1 ± 2.1 0.003
   remodeling –3.3 ± 2.6 –1.6 ± 2.2 0.01
PWT [mm] 12.6 ± 1.7 10.7 ± 2.4 < 0.001 11.9 ± 1.9 11.1 ± 1.2 0.12
   remodeling –2.1 ± 2.1 –0.6 ± 2.1 0.012
LVMI [g/m2] 161.5 ± 49.4 108.9 ± 28.3 < 0.001 148.6 ± 31 120.8 ± 28.4 0.001
   remodeling –55.8 ± 36 –28.4 ± 34 0.004
LVEF (%) 57.6 ± 11.1 63.3 ± 8.2 0.001 59.1 ± 13.4 62.5 ± 9.5 0.26
   remodeling +5.3 + 9.4 +4.4 + 14.5 0.74
CA– — absence of angiographic coronary stenosis; CA+ — moderate coronary atherosclerosis; Pre — preoperative; Post — postoperative;
LVEDD — end-diastolic left ventricular dimension; LVESD — end-systolic left ventricular dimension; IVS — interventricular septum thickness;
PWT — posterior wall thickness; LVMI — left ventricular mass index; LVEF —  left ventricular ejection fraction
Figure 1. Differences in left ventricular mass index (LVMI)
absolute reverse remodeling between CA– and CA+.
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Discussion
Left ventricular pressure overload due to aor-
tic valve stenosis leads to a marked myocardial
hypertrophy. AVR immediately reduces this pres-
sure overload, conditioning a decrease in wall ten-
sion and a reverse LV remodeling with LVMI re-
gression due to ventricular dimensions and myo-
cardial thickness reduction, well known during the
first 12 months [1, 4, 5] and sustained many years
after surgery [6, 7]. The role of coronary athero-
sclerosis in this reverse ventricular remodeling is
not well defined in the literature. Some authors have
said that severe myocardial hypertrophy in patients
with severe AS can promote coronary microcircu-
latory function abnormalities [8], reduction of dias-
tolic perfusion, and increase of systolic impedance
to coronary flow due to perivascular compression
[9]. Improving diastolic perfusion while reducing
perivascular compression due to pressure overload
drop after AVR is the main mechanism to improve
myocardial blood flow and restore the coronary va-
sodilatation reserve [10], reducing the tissular is-
chemia and facilitating molecular mechanisms (in-
activation of metaloproteinases that promote inter-
stitial fibrosis) [11] that determine the reverse
ventricular remodeling.
Biedermann et al. [12] described specifically
how, one year after AVR, in patients with CA+ the
left ventricular hypertrophy (LVH) regressed more
slowly. But in that study, patients with moderate
coronary stenosis, as well as patients who received
CABG, were included in group CA+. These revas-
cularized patients (CABG) could have equalized their
risk with CA– patients. We aimed to study the spe-
cific role of moderate atherosclerosis, and its coro-
nary flow disturbance impact, on long-term LVH
regression. Our results concur with those published
by Biedermann et al. [12], with a significant reduc-
tion in LVMI at three years in both groups: in our
sample, reduction in LVMI is progressive and re-
mains throughout in both groups, but it is signifi-
cantly more intense in CA– than in CA+, probably
because of a longer follow-up time (one year vs
three years), and the different imaging technique
used (cardiac magnetic resonance).
In the same way, observed changes in LV di-
mensions and wall thickness (LVEDD, LVESD and
PWT) were more intense in the CA– group, and the
absolute drop in measurements of LVEDD, PWT
and IVS were significantly higher in CA– than in
CA+, a fact that suggests poorer ventricular con-
ditioning or reverse remodeling in the presence of
non-revascularized moderate coronary atheroscle-
rosis. With respect to LVEF, our results also agree
with those described in the literature, with a simi-
lar improvement during long-term follow-up inde-
pendently of the degree of coronary atherosclerosis.
Although in our study there were more males
than females in the CA+ group, many studies have
described the absence of gender influence on LVH
regression after AVR for AS [12, 13], so we do not
consider this basal difference in the groups studied
could have influenced the final results.
Hypertension is the only cardiovascular risk
factor considered as a potential mechanism to de-
lay or avoid the long-term LV mass regression af-
ter AVR: in a ten year follow-up study, it was the
only independent factor of LVH after surgery [13].
In our study, this cardiovascular risk factor present-
ed the same prevalence in both groups, so we can
expect that the results have not been influenced by
it. Further studies with a longer follow-up would be
necessary to see if advancing age could increase the
prevalence of hypertension and determine different
results, or reinforce those we present.
Except in cases with severely impaired LVEF,
our echocardiographic study protocol for aortic
stenosis did not include the assessment of aortic
valve area by continuity equation. Due to the low
prevalence of systolic dysfunction in our sample, we
did not evaluate patient-prosthesis missmatch
(PPM) in our study. PPM seems to play an out-
standing role in LV mass regression after aortic
valve replacement. As has been recently demon-
strated with the clinical outcome and mortality of
these patients [14], PPM is only relevant in LVMI
evolution after AVR in the presence of systolic dys-
function prior to surgery [15]. It is only in this sub-
group of patients that PPM seems to determine an
incomplete LVMI regression. Some authors have
suggested that this may not be so relevant in LV
remodeling after AVR for AS [16, 17]. The low and
similar prevalence of systolic dysfunction between
both groups in our sample, as well as the absence
of severely elevated transvalvular gradients after
surgery, could suggest a poor influence of possible
cases of PPM in our results.
Clinical implications
Although LVH late after AVR for AS is associa-
ted with an increased morbidity (impaired exercise
capacity, a higher New York Heart Association dys-
pnoea class, a tendency for more frequent chest
pain), it has not been related to increased mortality
[18]. Because of this, and the fact that LVEF (the
main surveillance predictor in patients after AVR
for AS) is a parameter that remains stable irrespec-
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tive of the degree of coronary atherosclerosis [11],
it is possible that in cases of moderate coronary
stenosis, not performing CABG during the AVR
could be a reasonable strategy, thereby reducing
surgical off-pump, cardioplegia and cross-clamp
times, and so lowering intraoperative risk and mor-
tality. After AVR and LVMI regression (improve-
ment in coronary flow and microcirculation) these
moderate coronary stenosis could be re-evaluated
and ischemia-driven revascularized by percutane-
ous coronary intervention if necessary.
Conclusions
After AVR for AS, non-revascularized mode-
rate coronary atherosclerosis determines a long-
-term lesser degree of LVH regression and a worse
absolute reverse remodeling of LVMI, LVEDD, IVS
and PWT.
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